SilkTech Biopharmaceuticals

SilkTech Biopharmaceuticals, also known as Silk Technologies, is a biotechnology research company specializing in the development of silk-derived protein (SDP) products for medical, consumer, and animal health applications. The company utilizes patented technology to create protein-based excipients that serve as safe, protective coatings and drug delivery vehicles. By leveraging the natural chemistry of silk proteins, SilkTech aims to provide health-promoting benefits while reducing the need for synthetic, potentially toxic ingredients in various therapeutic and consumer formulations.

Through its subsidiary or brand entity, SilkTears, the company has developed a preservative-free, doctor-formulated lubricating eye drop designed for the temporary relief of dry eye symptoms. These eye drops incorporate a proprietary silk-derived protein as an inactive wetting agent and are manufactured in compliance with FDA OTC monograph requirements. SilkTech’s work is supported by multiple government-funded research awards, including projects related to ocular surface regeneration and trauma, and the company continues to advance its technology to improve patient care and product formulation integrity across the biopharmaceutical sector.